Palvella Therapeutics (PVLA) Return on Capital Employed (2016 - 2024)
Historic Return on Capital Employed for Palvella Therapeutics (PVLA) over the last 10 years, with Q3 2024 value amounting to 0.2%.
- Palvella Therapeutics' Return on Capital Employed rose 10200.0% to 0.2% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.2%, marking a year-over-year increase of 10200.0%. This contributed to the annual value of 0.24% for FY2023, which is 2500.0% up from last year.
- As of Q3 2024, Palvella Therapeutics' Return on Capital Employed stood at 0.2%, which was up 10200.0% from 0.15% recorded in Q2 2024.
- Palvella Therapeutics' Return on Capital Employed's 5-year high stood at 0.2% during Q3 2024, with a 5-year trough of 1.12% in Q1 2023.
- Moreover, its 5-year median value for Return on Capital Employed was 0.48% (2021), whereas its average is 0.42%.
- Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by -6100bps in 2023, then skyrocketed by 12900bps in 2024.
- Quarter analysis of 5 years shows Palvella Therapeutics' Return on Capital Employed stood at 0.38% in 2020, then fell by -24bps to 0.48% in 2021, then plummeted by -50bps to 0.72% in 2022, then skyrocketed by 47bps to 0.38% in 2023, then skyrocketed by 152bps to 0.2% in 2024.
- Its last three reported values are 0.2% in Q3 2024, 0.15% for Q2 2024, and 0.17% during Q1 2024.